A VCU Massey Comprehensive Cancer Center therapy has achieved in preclinical models to improve disease survival A VCU Massey Comprehensive Cancer Center team has developed a therapy that selectively slows the progression of acute myeloid leukemia (AML) in preclinical models while protecting surrounding healthy tissue. This latest generation therapy has achieved an improvement in survival and a decrease in side effects compared to conventional tr…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A VCU Massey Comprehensive Cancer Center therapy has achieved in preclinical models to improve disease survival A VCU Massey Comprehensive Cancer Center team has developed a therapy that selectively slows the progression of acute myeloid leukemia (AML) in preclinical models while protecting surrounding healthy tissue. This latest generation therapy has achieved an improvement in survival and a decrease in side effects compared to conventional tr…